Juha P. Risteli

Q: What Schools Are Affiliated With Juha P. Risteli

Juha P. Risteli is affiliated with the following schools: University of Copenhagen, University of Oulu

Juha P. Risteli's AcademicInfluence.com Rankings

Juha P. Risteli

Biology

#8559

World Rank

#11656

Historical Rank

Biochemistry

#1244

World Rank

#1363

Historical Rank

biology Degrees

Download Badge

Biology

Juha P. Risteli's Degrees

PhD Biochemistry University of Helsinki
Masters Biochemistry University of Helsinki

Why Is Juha P. Risteli Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Juha P. Risteli's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. (1993) (666)
Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. (1990) (553)
Mannose Receptor-Mediated Regulation of Serum Glycoprotein Homeostasis (2002) (461)
Serum markers of type I collagen formation and degradation in metabolic bone disease: Correlation with bone histomorphometry (1993) (449)
The Type I Collagen Fragments ICTP and CTX Reveal Distinct Enzymatic Pathways of Bone Collagen Degradation (2003) (435)
Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. (1988) (360)
Polymerization of Type I and III Collagens Is Dependent On Fibronectin and Enhanced By Integrins α11β1and α2β1 * (2002) (331)
Immunoassay for intact amino-terminal propeptide of human type I procollagen. (1996) (284)
7-S collagen: characterization of an unusual basement membrane structure. (1980) (272)
Aberrant type I and type III collagen gene expression in human breast cancer in vivo (1998) (249)
Biochemical markers of bone metabolism. (1993) (231)
Circulating C-terminal propeptide of type I procollagen is cleared mainly via the mannose receptor in liver endothelial cells. (1990) (228)
Increased content of type III collagen at the rupture site of human Achilles tendon (2002) (216)
Smoking affects collagen synthesis and extracellular matrix turnover in human skin (2002) (183)
The mechanism of action of induced membranes in bone repair. (2013) (182)
Macromolecular structure of basement membrane collagens (1981) (181)
Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin K. (2000) (175)
Clearance of NH2-terminal propeptides of types I and III procollagen is a physiological function of the scavenger receptor in liver endothelial cells (1994) (165)
Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio. (2005) (159)
Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma. (1992) (157)
Diurnal variation in serum markers of type I collagen synthesis and degradation in healthy premenopausal women (1992) (151)
Apoptosis and apoptosis-related proteins in human endometrium (2000) (142)
The O75X adhesin of uropathogenic Escherichia coli is a type IV collagen‐binding protein (1989) (142)
Fibrosis in endstage human heart failure: severe changes in collagen metabolism and MMP/TIMP profiles. (2011) (136)
Analysing connective tissue metabolites in human serum. Biochemical, physiological and methodological aspects. (1995) (133)
Atrial extracellular matrix remodelling in patients with atrial fibrillation (2007) (128)
Osteoblast recruitment from stem cells does not decrease by age at late adulthood. (2003) (128)
Collagen scar formation after acute myocardial infarction: relationships to infarct size, left ventricular function, and coronary artery patency. (1997) (125)
The effect of topical oestradiol on skin collagen of postmenopausal women (1995) (124)
Serum Concentrations of the Type I and III Procollagen Propeptides as Biochemical Markers of Growth Velocity in Healthy Infants and Children and in Children with Growth Disorders (1991) (121)
Structural diversity and domain composition of a unique collagenous fragment (intima collagen) obtained from human placenta. (1983) (120)
Synthesis of type I collagen in healing wounds in humans. (1991) (119)
Assessment of bone remodeling using biochemical indicators of type I collagen synthesis and degradation: relation to calcium kinetics. (1994) (116)
MT1-MMP is required for myeloid cell fusion via regulation of Rac1 signaling. (2010) (116)
Type IV collagen and laminin‐related antigens in human serum in alcoholic liver disease (1985) (115)
A novel organotypic model mimics the tumor microenvironment. (2009) (114)
Immunohistochemical study of type I collagen and type I pN‐collagen in benign and malignant ovarian neoplasms (1995) (108)
Genetic influences on type I collagen synthesis and degradation: further evidence for genetic regulation of bone turnover. (1994) (103)
Concomitant i.v. and oral clodronate in the relief of bone pain--a double-blind placebo-controlled study in patients with prostate cancer. (1997) (102)
Concurrent p53 expression in bronchial dysplasias and squamous cell lung carcinomas. (1993) (102)
Markers of fibrogenesis and basement membrane formation in alcoholic liver disease. Relation to severity, presence of hepatitis, and alcohol intake. (1990) (101)
Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms. (2001) (101)
Sensitive radioimmunoassays for 7 S collagen and laminin: application to serum and tissue studies of basement membranes. (1981) (99)
Aminoterminal propeptide of type III procollagen in serum in alcoholic liver disease (1983) (99)
p53 immunohistochemistry in transitional cell carcinoma and dysplasia of the urinary bladder correlates with disease progression. (1993) (98)
Laminin and its neurite outgrowth‐promoting domain in the brain in Alzheimer's disease and Down's syndrome patients (1992) (98)
A new method to measure type I and III collagen synthesis in human skin in vivo: demonstration of decreased collagen synthesis after topical glucocorticoid treatment. (1992) (94)
Biochemical markers of bone formation and resorption around parturition and during lactation in dairy cows with high and low standard milk yields. (2000) (89)
Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer. (1995) (89)
Different pattern of collagen cross-links in two sclerotic skin diseases: lipodermatosclerosis and circumscribed scleroderma. (2001) (87)
Measurement of aminoterminal propeptide of type I procollagen (PINP) in serum. (2012) (84)
Serum procollagen peptides and collagen type VI for the assessment of activity and degree of hepatic fibrosis in schistosomiasis and alcoholic liver disease (1992) (84)
Serum Macrophage Inhibitory Cytokine-1 Concentrations Correlate with the Presence of Prostate Cancer Bone Metastases (2007) (83)
Purification and characterization of the N-terminal propeptide of human type III procollagen. (1985) (83)
The carboxy-terminal propeptide of type I procollagen in serum as a marker of bone formation: the effect of nandrolone decanoate and female sex hormones. (1991) (82)
Activities of prolyl hydroxylase, lysyl hydroxylase, collagen galactosyltransferase and collagen glucosyltransferase in the liver of rats with hepatic injury. (1974) (81)
Thrombolytic Therapy With Streptokinase Stimulates Collagen Breakdown (1991) (80)
Evaluation of the effect of oral clodronate on skeletal metastases with type 1 collagen metabolites. A controlled trial of the Finnish Prostate Cancer Group. (1993) (79)
Heterogeneity of the antigens related to the aminoterminal propeptide of type III procollagen in human serum. (1982) (79)
Transdermal oestrogen therapy protects postmenopausal liver transplant women from osteoporosis. A 2-year follow-up study. (2001) (77)
Effect of age and diabetes on type IV collagen and laminin in human kidney cortex. (1986) (76)
Elevated serum levels of type I collagen degradation marker ICTP and tissue inhibitor of metalloproteinase (TIMP) 1 are associated with poor prognosis in lung cancer. (2001) (75)
Estrogen reduces the depth of resorption pits by disturbing the organic bone matrix degradation activity of mature osteoclasts. (2001) (72)
Systemic glucocorticoid treatment decreases serum concentrations of carboxyterminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen (1992) (72)
PINP: a serum biomarker of bone formation in the rat. (2007) (71)
Type I and III collagens in human colon cancer and diverticulosis. (2000) (70)
Systemic therapy with estrogen or estrogen with progestin has no effect on skin collagen in postmenopausal women. (1997) (70)
Comparison of bone resorption markers during hypocalcemia in dairy cows. (1998) (69)
Type I and type III collagen synthesis and composition in the valve matrix in aortic valve stenosis. (2006) (69)
The hypoxic tumor microenvironment regulates invasion of aggressive oral carcinoma cells. (2013) (69)
Osteogenic Differentiation of Human Mesenchymal Stem cells in a 3D Woven Scaffold (2018) (69)
Markers of bone turnover in patients with differentiated thyroid cancer with and following withdrawal of thyroxine suppressive therapy. (1998) (69)
Radiological and biochemical resolution of nutritional rickets with calcium (2003) (68)
Collagen propeptides as indicators of collagen assembly. (1995) (68)
Intracellular enzymes of collagen biosynthesis in rat liver as a function of age and in hepatic injury induced by dimethylnitrosamine. Changes in prolyl hydroxylase, lysyl hydroxylase, collagen galactosyltransferase and collagen glucosyltransferase activities. (1976) (68)
Systemic glucocorticoids decrease the synthesis of type I and type III collagen in human skin in vivo, whereas isotretinoin treatment has little effect (1994) (68)
Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinoma. (1996) (65)
Increased type I collagen degradation correlates with disease severity in rheumatoid arthritis. (1993) (64)
Increased expression of collagen types I and III in human skin as a consequence of radiotherapy (2002) (63)
Intracellular enzymes of collagen biosynthesis in rat liver as a function of age and in hepatic injury induced by dimethylnitrosamine. Purification of rat prolyl hydroxylase and comparison of changes in prolyl hydroxylase activity with changes in immunoreactive prolyl hydroxylase. (1976) (62)
Growth velocity, growth hormone therapy, and serum concentrations of the amino-terminal propeptide of type III procollagen. (1989) (62)
Bone metabolism of milk goats and sheep during second pregnancy and lactation in comparison to first lactation. (2007) (61)
Two year randomized controlled trial of etidronate in rheumatoid arthritis: changes in serum aminoterminal telopeptides correlate with radiographic progression of disease. (2003) (61)
Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension. (2004) (61)
Type IV collagen and laminin in slow and fast skeletal muscle in rats--effects of age and life-time endurance training. (1988) (60)
Human mesenchymal stem cell derived osteoblasts degrade organic bone matrix in vitro by matrix metalloproteinases. (2005) (60)
Increased degradation of type I collagen in patients with inflammatory bowel disease. (1996) (59)
Discontinuity of the basement membrane in fibrosing basocellular carcinomas and basosquamous carcinomas of the skin: an immunohistochemical study with human laminin and type IV collagen antibodies. (1984) (59)
Role of estrogen deficiency in pathogenesis of secondary hyperparathyroidism and increased bone resorption in elderly women. (1997) (58)
Analysis of extracellular matrix proteins in biological fluids. (1987) (58)
Estrogen Reduces the Depth of Resorption Pits by Disturbing the Organic Bone Matrix Degradation Activity of Mature Osteoclasts. (2001) (58)
Effects of an inhaled steroid (budesonide) on skin collagen synthesis of asthma patients in vivo. (1996) (57)
Cytokines, interstitial collagen and ventricular remodelling in dilated cardiomyopathy. (2008) (57)
Identification of a new basement membrane collagen by the aid of a large fragment resistant to bacterial collagenase (1979) (56)
Inhibition of cyclooxygenase-2 down-regulates osteoclast and osteoblast differentiation and favours adipocyte formation in vitro. (2007) (55)
The production of collagen and the activity of mast‐cell chymase increase in human skin after irradiation therapy (2004) (55)
Secretome profiling of oral squamous cell carcinoma-associated fibroblasts reveals organization and disassembly of extracellular matrix and collagen metabolic process signatures (2016) (55)
Serum aminoterminal type III procollagen peptide and the 7S domain of type IV collagen in patients with alcohol abuse. Relation to ultrastructural fibrosis in the acinar zone 3 and to serum hyaluronan. (2008) (55)
Progressive ovarian carcinoma induces synthesis of type I and type III procollagens in the tumor tissue and peritoneal cavity. (1993) (55)
The response evaluation of bone metastases in mammary carcinoma. The value of radiology, scintigraphy, and biochemical markers of bone metabolism (1987) (54)
Aminoterminal propeptide of type III procollagen in healing wound in humans. (1987) (54)
Congenital pseudarthrosis of neurofibromatosis type 1: impaired osteoblast differentiation and function and altered NF1 gene expression. (2009) (53)
The effects of first gestation and lactation on bone metabolism in dairy goats and milk sheep. (2006) (53)
Autoantibodies binding to citrullinated telopeptide of type II collagen and to cyclic citrullinated peptides predict synergistically the development of seropositive rheumatoid arthritis (2007) (53)
Markers of Type I and Type III Collagen Turnover, Insulin-Like Growth Factors, and Their Binding Proteins in Cord Plasma of Small Premature Infants: Relationships with Fetal Growth, Gestational Age, Preeclampsia, and Antenatal Glucocorticoid Treatment (2001) (53)
Synthesis and degradation of type IV collagen in rat skeletal muscle during immobilization in shortened and lengthened positions. (2003) (52)
Type III and type I procollagen markers in fibrosing alveolitis. (1999) (52)
Estrogen responsiveness of bone formation in vitro and altered bone phenotype in aged estrogen receptor-alpha-deficient male and female mice. (2005) (52)
Increased amount of type III pN-collagen in human abdominal aortic aneurysms: evidence for impaired type III collagen fibrillogenesis. (2000) (52)
Aminoterminal propeptide of type III procollagen in serum during wound healing in human beings. (1990) (51)
Anticitrulline antibodies can be caused by homocitrulline-containing proteins in rabbits. (2010) (51)
Type I and Type III Collagen Metabolites as Predictors of Clinical Outcome in Epithelial Ovarian Cancer (1999) (51)
Pachydermoperiostosis: analysis of the connective tissue abnormality in one family. (1994) (51)
Procollagen synthesis and extracellular matrix deposition in MG‐63 osteosarcoma cells (1993) (50)
Prolyl 3-hydroxylase: partial characterization of the enzyme from rat kidney cortex. (1977) (50)
External thoracic duct-venous shunt in conscious pigs for long term studies of connective tissue metabolites in lymph. (1990) (50)
Toll-like receptor 9 ligands enhance mesenchymal stem cell invasion and expression of matrix metalloprotease-13. (2010) (50)
Cross-linked telopeptides of type I and III collagens in malignant ovarian tumours in vivo (1999) (50)
High dietary intake of retinol leads to bone marrow hypoxia and diaphyseal endosteal mineralization in rats. (2011) (49)
Collagen metabolism and growth in prepubertal children with asthma treated with inhaled steroids. (1998) (49)
Extracellular matrix alterations and acute inflammation; developing in parallel during early induction of pulmonary fibrosis (2012) (49)
Collagen biosynthesis enzymes in serum and hepatic tissue in liver disease (1979) (49)
Changes in interstitial collagen metabolism during acute myocardial infarction treated with streptokinase or tissue plasminogen activator. (1996) (49)
Laminin and type IV collagen in the human testis. (1985) (48)
Intraluminal fibromyxoid lesions in bronchiolitis obliterans organizing pneumonia are highly capillarized. (1999) (48)
Aggressive breast cancer leads to discrepant serum levels of the type I procollagen propeptides PINP and PICP. (1997) (48)
Modulation of skin collagen metabolism by irradiation: collagen synthesis is increased in irradiated human skin (2000) (48)
Amino acid sequence of the N-terminal aggregation and cross-linking region (7S domain) of the alpha 1 (IV) chain of human basement membrane collagen. (1985) (47)
Modulation of collagen synthesis and mRNA by continuous and intermittent use of topical hydrocortisone in human skin (2003) (47)
Prediction of disease progression in early rheumatoid arthritis by ICTP, RF and CRP. A comparative 3-year follow-up study. (2000) (47)
Interleukin-6 and tumor necrosis factor alpha in relation to myocardial infarct size and collagen formation. (2003) (47)
Immunohistochemical study of basement membrane proteins and type III procollagen in myelofibrosis (1986) (46)
Intracellular Enzymes of Collagen Biosynthesis in Rat Kidney in Streptozotocin Diabetes (1976) (45)
Complete processing of type III collagen in atherosclerotic plaques. (1999) (44)
Serum PINP, PIIINP, galectin-3, and ST2 as surrogates of myocardial fibrosis and echocardiographic left venticular diastolic filling properties (2015) (44)
Type I procollagen synthesis is regulated by steroids and related hormones in human osteosarcoma cells (1998) (44)
Effects of a combined estrogen‐gestagen regimen on serum levels of the carboxy‐terminal propeptide of human type I procollagen in osteoporosis (1991) (44)
Pimecrolimus Cream 1% in the Treatment of Lichen Sclerosus (2006) (44)
Influence of different calcium contents in diets supplemented with anionic salts on bone metabolism in periparturient dairy cows. (2007) (43)
Separation of prolyl 3-hydroxylase and 4-hydroxylase activities and the 4-hydroxyproline requirement for synthesis of 3-hydroxyproline. (1977) (43)
Difference between total and intact assays for N-terminal propeptide of type I procollagen reflects degradation of pN-collagen rather than denaturation of intact propeptide (2010) (42)
Diurnal variation in concentrations of various markers of bone metabolism in dogs. (1999) (42)
Application of markers of collagen metabolism in serum and synovial fluid for assessment of disease process in patients with rheumatoid arthritis. (1995) (42)
Type I collagen turnover and cross-linking are increased in irradiated skin of breast cancer patients. (2001) (42)
Influence of different calcium concentrations in the diet on bone metabolism in growing dairy goats and sheep. (2005) (42)
Immunohistochemical Evidence that Lung Carcinomas Grow on Alveolar Basement Membranes (1990) (41)
Recovery of human skin collagen synthesis after short‐term topical corticosteroid treatment and comparison between young and old subjects (1996) (41)
Vitamin D supplementation has minor effects on parathyroid hormone and bone turnover markers in vitamin D-deficient bedridden older patients. (2008) (41)
Expression of mRNAs for type I and type III procollagens in serous ovarian cystadenomas and cystadenocarcinomas. (1996) (41)
Type I and III collagen protein precursors and mRNA in the developing human lung (2004) (41)
Serum aminoterminal propeptide of type III procollagen: a potential predictor of the response to growth hormone therapy. (1988) (41)
Immunological characterization of the 7-S domain of type IV collagens. (1981) (40)
Variability in the precursor proteins of collagen I and III in different stages of COPD (2010) (40)
Tenascin-C and type I and III collagen expression in total Achilles tendon rupture. An immunohistochemical study. (2009) (40)
Extracellular matrix proteins and myofibroblasts in granulomas of sarcoidosis, atypical mycobacteriosis, and tuberculosis of the lung. (2007) (39)
Effect of hydrocortisone, methylprednisolone aceponate and momethasone furoate on collagen synthesis in human skin in vivo. (1997) (39)
Markers of collagen synthesis and degradation are increased in serum in severe sepsis: a longitudinal study of 44 patients (2009) (39)
Effects of low‐ and conventional‐dose transcutaneous HRT over 2 years on bone metabolism in younger and older postmenopausal women (1996) (38)
New insights to the role of aryl hydrocarbon receptor in bone phenotype and in dioxin-induced modulation of bone microarchitecture and material properties. (2013) (38)
Treatment of hypertrophic scars and keloids with a radiofrequency device: A study of collagen effects (2005) (37)
Decreased Protein C Activation Is Associated With Abnormal Collagen Turnover in the Intraalveolar Space of Patients With Interstitial Lung Disease (2000) (37)
Possible variation in bone resorption during the normal menstrual cycle. (1993) (37)
Bone and Mineral Metabolism (2012) (37)
Amino-terminal propeptide of type III procollagen: a new prognosis indicator in human ovarian cancer. (1989) (37)
Serum immunoreactive prolyl hydroxylase in liver disease (1977) (36)
Products of Bone Collagen Metabolism (2006) (36)
Comparison of three serum assays for bone collagen formation during postmenopausal estrogen-progestin therapy. (1997) (36)
Immunoelectron microscopic localization of laminin, type IV collagen, and type III pN-collagen in reticular fibers of human lymph nodes. (1989) (35)
Changes in bone markers in children with asthma during inhaled budesonide and nedocromil treatments (1996) (35)
Aminoterminal propeptide of type III procollagen in methotrexate‐induced liver fibrosis and cirrhosis (1988) (35)
Short-Term Intermittent Intravenous Clodronate in the Prevention of Bone Loss Related to Chemotherapy-Induced Ovarian Failure (2004) (35)
Influence of phytase added to a vegetarian diet on bone metabolism in pregnant and lactating sows. (2005) (35)
Type I and III procollagen propeptides in growth hormone-deficient patients: effects of increasing doses of GH. (1991) (35)
Type I collagen degradation product in serum of patients with early rheumatoid arthritis: relationship to disease activity and radiological progression in a 3-year follow-up. (1994) (35)
Comparison of total and intact aminoterminal propeptide of type I procollagen assays in patients with breast cancer with or without bone metastases (2011) (35)
Monitoring of veno-occlusive disease after bone marrow transplantation by serum aminopropeptide of type III procollagen (1993) (35)
Markers of type I and type III collagen synthesis in serum as indicators of tissue growth during pregnancy. (1993) (34)
Serum type I collagen degradation markers, ICTP and CrossLaps, are factors for poor survival in lung cancer. (1999) (34)
Tenascin-C and fibronectin expression divide early stage tongue cancer into low- and high-risk groups (2017) (34)
Are there autoantibodies reacting against citrullinated peptides derived from type I and type II collagens in patients with rheumatoid arthritis? (2005) (34)
Basement membrane laminin and type IV collagen in endometrial adenocarcinoma: relation to differentiation and treatment. (1985) (33)
Atrial natriuretic peptide, B-type natriuretic peptide, and serum collagen markers after acute myocardial infarction. (2004) (33)
Type I collagen metabolites as tumor markers in patients with lung carcinoma (1999) (33)
Partial purification and characterization of chick-embryo prolyl 3-hydroxylase. (1979) (33)
Genitourinary prolapse and joint hypermobility are associated with altered type I and III collagen metabolism (2011) (33)
Early degradation and serum appearance of type I collagen fragments after myocardial infarction. (2004) (32)
Short-Term Changes in Serum PINP Predict Long-Term Changes in Trabecular Bone in the Rat Ovariectomy Model (2008) (32)
Demonstration of increased collagen synthesis in irradiated human skin in vivo. (1998) (32)
Fibrotic process and drug metabolism in alcoholic liver disease (1986) (32)
Comparison of the effect of hydrocortisone, hydrocortisone-17-butyrate and betamethasone on collagen synthesis in human skin in vivo. (1995) (32)
Influence of dietary phosphorus deficiency with or without addition of fumaric acid to a diet in pigs on bone parameters. (2002) (32)
Effect of prednisolone on the activities of the intracellular enzymes of collagen biosynthesis in rat liver and skin (1977) (32)
Assays of type I procollagen domains and collagen fragments: problems to be solved and future trends. (1997) (32)
Rheumatoid arthritis antigens homocitrulline and citrulline are generated by local myeloperoxidase and peptidyl arginine deiminases 2, 3 and 4 in rheumatoid nodule and synovial tissue (2016) (31)
Serum markers for type IV collagen and type III procollagen in the myelofibrosis‐osteomyelosclerosis syndrome and other chronic myeloproliferative disorders (1986) (31)
Aminoterminal propeptide of type I procollagen (PINP) correlates to bone loss and predicts the efficacy of antiresorptive therapy in pre- and post-menopausal non-metastatic breast cancer patients. (1998) (31)
Macrophage colony-stimulating factor 1, a clinically useful tumor marker in endometrial adenocarcinoma: comparison with CA 125 and the aminoterminal propeptide of type III procollagen. (1995) (31)
Regulation of type IV collagen gene expression and degradation in fast and slow muscles during dexamethasone treatment and exercise (2004) (31)
Serum type I procollagen peptide: a non-invasive index of bone formation in patients on haemodialysis? (1994) (30)
Basement membrane laminin and type IV collagen in various benign and malignant adnexal tumors of the skin: an immunohistochemical study. (1984) (30)
Serum basement membrane and type III procollagen-related antigens in primary biliary cirrhosis. (1988) (30)
The interplay of matrix metalloproteinase-8, transforming growth factor-β1 and vascular endothelial growth factor-C cooperatively contributes to the aggressiveness of oral tongue squamous cell carcinoma (2017) (29)
Type I and III collagen degradation products in serum predict patient survival in head and neck squamous cell carcinoma. (2012) (29)
Serum osteocalcin and carboxyterminal propeptide of type I procollagen in rheumatoid arthritis. (1993) (29)
Monitoring the action of clodronate with type I collagen metabolites in multiple myeloma. (1996) (29)
Organization of type III collagen in benign and malignant ovarian tumors. An immunohistochemical study (1993) (28)
Type I and III collagen metabolites as predictors of clinical outcome in epithelial ovarian cancer. (1999) (28)
Nonselective matrix metalloproteinase but not tumor necrosis factor-α inhibition effectively preserves the early critical colon anastomotic integrity (2011) (28)
Human Bone Marrow Mesenchymal Stem Cells Induce Collagen Production and Tongue Cancer Invasion (2013) (28)
Type IV collagens' isolation and characterization of 7S collagen from human kidney, liver and lung. (1981) (28)
The definition of fibrogenic processes in fibroblastic foci of idiopathic pulmonary fibrosis based on morphometric quantification of extracellular matrices. (2009) (27)
Four automated 25-OH total vitamin D immunoassays and commercial liquid chromatography tandem-mass spectrometry in Finnish population. (2013) (27)
Treatment of psoriasis vulgaris with topical calcipotriol has no short-term effect on calcium or bone metabolism. A randomized, double-blind, placebo-controlled study. (1993) (27)
Aminoterminal propeptide of type III procollagen in serum—an indicator of clinical behavior of advanced ovarian carcinoma? (1988) (27)
Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide (2005) (27)
Connective tissue response to major surgery and postoperative infection (1992) (27)
Serum ionized calcium, intact PTH and novel markers of bone turnover in bedridden elderly patients (1994) (27)
Preferential hydroxylation of type IV collagen by lysyl hydroxylase from Ehlers-Danlos syndrome type VI fibroblasts. (1980) (27)
The extracellular matrix in skin tumor development – a morphological study (1999) (27)
Serum type III procollagen and basement membrane proteins as noninvasive markers of hepatic pathology in Indian childhood cirrhosis (1987) (25)
Effects of long-term inhaled corticosteroids on skin collagen synthesis and thickness in asthmatic patients. (1998) (25)
Collagen Synthesis in Intact Skin Is Suppressed During Wound Healing (1993) (25)
Effect of the menopause and hormone replacement therapy on the carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen (1994) (25)
Synthesis and breakdown of fibrillar collagens: concomitant phenomena in ovarian cancer. (1998) (25)
Diurnal variation in concentrations of various markers of bone metabolism in growing female goats and sheep (2003) (25)
Differently cross-linked and uncross-linked carboxy-terminal telopeptides of type I collagen in human mineralised bone. (2004) (24)
Low incidence of osteoporosis in a two year follow-up of early community based patients with rheumatoid arthritis. (1998) (24)
Seasonal changes in plasma nitrogenous compounds of the European brown bear (Ursus arctos arctos) (1998) (24)
Prognostic Value of Serum Hyaluronic Acid and Type I and III Procollagen Propeptides in Extrahepatic Biliary Atresia (1995) (24)
Lymphatic clearance of synovial fluid in conscious pigs: the aminoterminal propeptide of type III procollagen (1993) (24)
Collagen metabolism in normal and complicated pregnancy: changes in the aminoterminal propeptide of type III procollagen in serum (1987) (24)
Low Parathyroid Hormone Levels in Bedridden Geriatric Patients with Vitamin D Deficiency (2009) (23)
Carbamyl adducts on low-density lipoprotein induce IgG response in LDLR-/- mice and bind plasma autoantibodies in humans under enhanced carbamylation. (2013) (23)
Assay for Cross-Linked Carboxyterminal Telopeptide of Type I Collagen (ICTP) Unlike CrossLaps Assay Reflects Increased Pathological Degradation of Type I Collagen in Rheumatoid Arthritis (2003) (23)
Validation of an automated intact N-terminal propeptide of type I procollagen (PINP) assay. (2010) (23)
Altered collagen expression in human dentin: increased reactivity of type III and presence of type VI in dentinogenesis imperfecta, as revealed by immunoelectron microscopy. (1994) (22)
Carboxyterminal telopeptide of type I collagen (ICTP) in predicting prognosis in epithelial ovarian cancer. (2001) (22)
Assessment of bone formation by biochemical markers in metabolic bone disease: Separation between osteoblastic activity at the cell and tissue level (1992) (22)
Increased collagen synthesis in psoriasis in vivo (2005) (22)
The Effects of High levels of Glucose and Insulin on Type I Collagen Synthesis in Mature Human Odontoblasts and Pulp Tissue in vitro (2001) (22)
Different amounts of protein-bound citrulline and homocitrulline in foot joint tissues of a patient with anti-citrullinated protein antibody positive erosive rheumatoid arthritis (2013) (22)
Very low rate of type I collagen synthesis and degradation in newly diagnosed children with acute lymphoblastic leukemia. (1997) (22)
Effect of cyclical intermittent etidronate therapy on circulating osteoprotegerin levels in patients with rheumatoid arthritis. (2003) (22)
The aminoterminal propeptide of type III procollagen and basement membrane components in serum during wound healing in man. (1988) (22)
Effect of hepatic injury on prolyl 3-hydroxylase and 4-hydroxylase activities in rat liver and on immunoreactive prolyl 4-hydroxylase concentrations in the liver and serum. (1978) (22)
The basement membrane proteins laminin and type IV collagen in isolated villi in pre-eclampsia. (1984) (21)
Postoperative PINP in serum reflects metastatic potential and poor survival in node-positive breast cancer. (2001) (21)
Elevated Collagen Turnover in Nigerian Children with Calcium-Deficiency Rickets (1997) (21)
Collagen synthesis in human skin in vivo: modulation by aging, ultraviolet B irradiation and localization. (1994) (21)
Immunoassay for the intact aminoterminal propeptide of human type I procollagen (PINP) (2006) (21)
The value of synovial fluid analysis in the assessment of knee joint destruction in arthritis in a three year follow up study (1999) (21)
Influence of a vegetarian diet versus a diet with fishmeal on bone in growing pigs. (2002) (21)
Neoplastic extracellular matrix environment promotes cancer invasion in vitro. (2016) (20)
Incorporation of sulphate into type III procollagen by cultured human fibroblasts. Identification of tyrosine O-sulphate. (1986) (20)
Increased type I collagen degradation in early rheumatoid arthritis. (1994) (20)
Separate and overlapping specificities in rheumatoid arthritis antibodies binding to citrulline- and homocitrulline-containing peptides related to type I and II collagen telopeptides (2015) (20)
Low Synthesis Rate of Type I Procollagen Is Normalized During Active Back Rehabilitation (1997) (20)
A thyroid hormone analogue, triiodothyroacetic acid, corrects corticosteroid-downregulated collagen synthesis. (2004) (19)
Serum concentrations of CA 125 and aminoterminal propeptide of type III procollagen (PIIINP) in patients with endometrial carcinoma (1990) (19)
Acute edematous and necrotic pancreatitis in a porcine model (2008) (19)
Simultaneous evaluation of epithelial cell function by CA 125 and stromal cell activity by aminoterminal propeptide of type III procollagen (PIIINP) in ovarian carcinoma. (1990) (19)
Trypsin-2 Enhances Carcinoma Invasion by Processing Tight Junctions and Activating ProMT1-MMP (2012) (19)
A rapid assay for prolyl 3-hydroxylase activity. (1978) (19)
Synthesis and maturation of type I and type III collagens in endometrial adenocarcinoma. (2004) (19)
Low free 25-hydroxyvitamin D and high vitamin D binding protein and parathyroid hormone in obese Caucasians. A complex association with bone? (2018) (19)
Basement membranes in progressing intraepithelial cervical neoplasia. An ultrastructural and immunohistochemical study with antibodies against human type IV collagen and laminin. (1985) (19)
Basement membrane research. (1981) (19)
Propeptide levels of type III and type I procollagen in the serum and bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis. (1997) (19)
Discrepant blood concentrations of type I procollagen propeptides in active Paget disease of bone. (1996) (18)
Familial high serum concentrations of the carboxyl-terminal propeptide of type I procollagen. (1994) (18)
Collagen metabolites in the prediction of response to GH therapy in short children. (1997) (18)
Bone markers in polycystic ovary syndrome: A multicentre study (2017) (18)
Markers of collagen and basement membrane metabolism in sera of patients with progressive systemic sclerosis. (1991) (18)
Collagen metabolism in gynecologic patients: changes in the concentration of the aminoterminal propeptide of type III procollagen in serum. (1990) (17)
Anti-Heparanase Aptamers as Potential Diagnostic and Therapeutic Agents for Oral Cancer (2014) (17)
Antibodies binding to citrullinated telopeptides of type I and type II collagens and to mutated citrullinated vimentin synergistically predict the development of seropositive rheumatoid arthritis (2012) (17)
Malotilate prevents accumulation of type III pN-collagen, type IV collagen, and laminin in carbon tetrachloride-induced pulmonary fibrosis in rats. (1989) (17)
Elevated serum ICTP concentrations reflect poor prognosis in patients with ovarian carcinoma. (1995) (16)
Atherosclerosis, type 1 collagen cross-linking and homocysteine. (2000) (16)
Metformin decreases bone turnover markers in polycystic ovary syndrome: a post hoc study. (2019) (16)
Radiation-induced changes in skin type I and III collagen synthesis during and after conventionally fractionated radiotherapy. (2004) (15)
Fate of circulating amino-terminal propeptide of type III procollagen in conscious pigs. (1993) (15)
Accumulation of laminin and type IV collagen in the kidney in congenital nephrosis. (1985) (15)
Connective tissue metabolites in serum as markers of disease activity in patients with rheumatoid arthritis. (1988) (15)
Effect of the structural components of basement membranes on the attachment of teratocarcinoma-derived endodermal cells. (1983) (15)
Action of topical thyroid hormone analogue, triiodothyroacetic acid in reversing glucocorticoid-induced skin atrophy in humans. (2006) (15)
New PCR-Based Method for the Sp1 Site Polymorphism in the COL1A1 Gene (2001) (14)
Effect of jaundice and its resolution on wound re-epithelization, skin collagen synthesis, and serum collagen propeptide levels in patients with neoplastic pancreaticobiliary obstruction. (2005) (14)
Immunohistochemical localization of epidermal basement membrane laminin and type IV collagen in bullous lesions of dermatitis herpetiformis (1984) (14)
Baseline expression and effect of TGF-β1 on Type I and III collagen mRNA and protein synthesis in human odontoblasts and pulp cellsIn Vitro (2001) (14)
Use of a marker of collagen formation in osteoporosis studies (2007) (13)
Significance of plasma levels of N-terminal Pro-B-type natriuretic peptide on left ventricular remodeling in non-obstructive hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene. (2008) (13)
Discrepant expression of carboxy- and aminoterminal propeptides of type I procollagen predicts poor clinical outcome in epithelial ovarian cancer. (2003) (13)
Comparison of carboxyterminal telopeptide of type I collagen (ICTP) and CA 125 as predictors of prognosis in ovarian cancer. (2004) (13)
SLOW ACCUMULATION OF BASEMENT MEMBRANE COLLAGEN IN KIDNEY CORTEX IN CONGENITAL NEPHROTIC SYNDROME (1982) (13)
Differential processing of type I and type III procollagens in the tumour cysts and peritoneal ascitic fluid of patients with benign and malignant ovarian tumours. (1994) (13)
Myocardial late gadolinium enhancement is associated with raised serum amino-terminal propeptide of type III collagen concentrations in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the α tropomyosin gene: magnetic resonance imaging study (2006) (13)
Erosive arthritis in a patient with pycnodysostosis: an experiment of nature. (2008) (13)
Effect of dextran on synthesis, secretion and deposition of type III procollagen in cultured human fibroblasts. (1991) (13)
Localization of precursor proteins and mRNA of type I and III collagens in usual interstitial pneumonia and sarcoidosis (2006) (12)
Partial Replacement of Animal Proteins with Plant Proteins for 12 Weeks Accelerates Bone Turnover Among Healthy Adults: A Randomized Clinical Trial. (2020) (12)
Characterization of the perivascular reticulin network in a case of primary brain lymphoma (1985) (12)
Markers of type I and III collagen turnover as indicators of growth velocity in very low birth weight infants. (2001) (12)
The predictive role of bone turnover markers for BMD in middle-aged men (2006) (12)
Efficacy and Toxicity of Intrathecal Liposomal Cytarabine in First-line Therapy of Childhood Acute Lymphoblastic Leukemia (2016) (12)
Influence of high-altitude grazing on bone metabolism of growing sheep. (2013) (12)
Characterization of Type I collagen synthesis and maturation in uterine carcinosarcomas (1999) (12)
Intracellular enzymes of collagen biosynthesis in 3T6 fibroblasts and chick-embryo tendon and cartilage cells. (1979) (12)
The effects of transdermal estrogen therapy on bone mass and turnover in early postmenopausal smokers: a prospective, controlled study. (2003) (12)
Aminoterminal propeptide of type III procollagen in serum in alcoholic liver disease. (1983) (12)
Effects of short‐term dexamethasone treatment on collagen synthesis and degradation markers in preterm infants with developing lung disease (2003) (11)
Inhibitory characteristics of citrullinated telopeptides of type I and II collagens for autoantibody binding in patients with rheumatoid arthritis. (2006) (11)
Increased amount of type III pN-collagen in AAA when compared with AOD. (2002) (11)
Type I collagen markers in cord serum of appropriate vs. small for gestational age infants born during the second half of pregnancy (2001) (11)
Change of diagnoses and outcome of patients with early inflammatory joint diseases during a mean 13‐month follow‐up (2007) (11)
Increase in circulating basement membrane antigens in diabetic rats and effects of insulin treatment (1982) (11)
Measuring collagen degradation (1993) (11)
Genetic and Constitutional Influences on Bone Turnover Markers: A Study of Male Twin Pairs (2007) (11)
Immunochemical distinction between two different chains of type IV collagen. (1980) (10)
Elevated preoperative serum ICTP is a prognostic factor for overall and disease-free survival in breast cancer. (2002) (10)
Autoimmune antibodies to collagen XIII in myasthenia gravis patients (2018) (10)
Measurement of collagen metabolism in skin diseases. A review of old and new techniques and their clinical applications (1993) (10)
The course of selected bone resorption marker concentrations in response to short-term hypocalcemia experimentally induced with disodium EDTA infusions in dairy cows. (2000) (10)
Aminoterminal propeptide of type III procollagen in ovarian cancer (1992) (10)
Baseline expression and effect of TGF-beta 1 on type I and III collagen mRNA and protein synthesis in human odontoblasts and pulp cells in vitro. (2001) (10)
Comparison of automated 25-OH vitamin D immunoassays with liquid chromatography isotope dilution tandem mass spectrometry. (2012) (10)
Serum markers of collagen synthesis and degradation in skin diseases. Altered levels in diseases with systemic manifestation and during systemic glucocorticoid treatment (2004) (9)
Homocitrulline: An Analog and Confounder Related to Citrulline (2014) (9)
Hexose sugars differentially alter collagen gene expression and synthesis in fibroblasts derived from granulation tissue, hypertrophic scar and keloid (2004) (9)
Amniotic fluid laminin and type IV collagen in normal and pathological pregnancies. (1985) (9)
Postoperative systemic corticosteroid treatment and Molteno implant surgery: a randomized clinical trial. (1999) (9)
Effects of vitamin D and calcium on markers of bone metabolism in geriatric patients with low serum 25-hydroxyvitamin D levels (2007) (9)
New lethal disease involving type I and III collagen defect resembling geroderma osteodysplastica, De Barsy syndrome, and Ehlers-Danlos syndrome IV. (1998) (9)
Dietary phosphorus intake is negatively associated with bone formation among women and positively associated with some bone traits among men-a cross-sectional study in middle-aged Caucasians. (2017) (9)
Increased collagen propeptides in the skin of a scleredema patient but no change in re-epithelialisation rate. (1996) (9)
Effect of inhaled beclomethasone on serum markers of collagen metabolism in postmenopausal asthmatic women. (1996) (9)
Stromal cells can be cultured and characterized from diagnostic bronchoalveolar fluid samples obtained from patients with various types of interstitial lung diseases (2014) (9)
The Effect of Zoledronic Acid on Serum Biomarkers among Patients with Chronic Low Back Pain and Modic Changes in Lumbar Magnetic Resonance Imaging (2019) (8)
Clinical Characteristics and Circulating Collagen and Laminin Metabolites in Insulin-Dependent Diabetic Children with Joint and Skin Manifestations (1993) (8)
Collagen formation in extracellular matrix of transplants of human transformed keratinocyte cell lines. (2002) (8)
Increased type I collagen synthesis in victims of sudden cardiac death due to idiopathic myocardial fibrosis (2014) (8)
Effect of Sucrose on Collagen Metabolism in Keloid, Hypertrophic Scar, and Granulation Tissue Fibroblast Cultures (2001) (8)
Procollagen I-expressing renin cell precursors. (2013) (8)
Combination drug strategy in recent‐onset rheumatoid arthritis suppresses collagen I degradation and is associated with retardation of radiological progression (2008) (8)
Effects of experimental nephrosis on basement-membrane components and enzymes of collagen biosynthesis in rat kidney. (1985) (8)
CHAPTER 23 – Products of Bone Collagen Metabolism (2006) (8)
Effect of short‐term antenatal dexamethasone administration on type I collagen synthesis and degradation in preterm infants at birth (2001) (8)
Serum biomarkers for Modic changes in patients with chronic low back pain (2021) (8)
Skin Collagen Synthesis Is Depressed in Patients with Severe Sepsis (2010) (8)
Aminoterminal propeptide of the alpha1-homotrimer variant of human type I procollagen (hotPINP) in malignant pleural effusion. (2001) (8)
Markers of Collagen Assembly and Turnover (1989) (8)
Carboxyterminal propeptide of type I procollagen in cerebrospinal fluid in childhood and in children with leukemia undergoing intrathecal treatment. (1991) (8)
Effect of topical tretinoin on non‐sun‐exposed human skin connective tissue: induction of tenascin but no major effect on collagen metabolism (1997) (8)
Type III collagen metabolism in soft tissue sarcomas. (1992) (8)
Bone alkaline phosphatase isoforms in chronic renal failure (2002) (7)
Procollagen assays in cancer. (2014) (7)
Natriuretic peptides and collagen biomarkers in patients with medical treatment for hypertension (2011) (7)
Sensitivity and specificity of autoantibodies binding to citrullinated carboxyterminal telopeptides of types I and II collagens in an early arthritis series. (2008) (7)
Radioimmunoassays for circulating basement membrane proteins: Laminin und 7 S collagen (1980) (7)
Aminoterminal propeptide of type III procollagen in cerebrospinal fluid. Variation with age and in childhood leukemia. (1991) (7)
Type I and type III collagen metabolites in adult osteosarcoma patients. (1996) (7)
Purification of porcine aminoterminal propeptide of type III procollagen from lymph and use for lymphatic clearance studies in pigs. (1992) (7)
Preoperative high type I collagen degradation marker ICTP reflects advanced breast cancer. (1999) (7)
Ehlers‐Danlos type IV: non‐invasive techniques as diagnostic support (1997) (7)
Gelsolin amyloid angiopathy causes severe disruption of the arterial wall (2016) (7)
Aminoterminal propeptide of type III procollagen (NP III), a new indicator of ovarian cancer aggressiveness: European Association of Gynaecologists and Obstetricians: 2nd Meeting, Paris, September 4–5,1987 (1988) (6)
Effect of oral clodronate on structural damage and bone turnover in rheumatoid arthritis. (2012) (6)
Chlorate inhibits tyrosine sulfation of human type III procollagen without affecting its secretion or processing. (1990) (6)
Appendix II: Extracellular Collagen Metabolites in Body Fluids (2003) (6)
Evaluation of IDS-iSYS intact parathyroid hormone (iPTH) and comparison to Siemens Advia Centaur iPTH assay in chronic renal failure patients and in controls. (2012) (6)
Collagen synthesis activity in the aqueous humour of eyes with glaucoma surgery: a pilot study. (1996) (6)
Sensitive immunoassays for the autoantibodies reacting against citrullinated carboxy-terminal telopeptides of type I and type II collagens in patients with rheumatoid arthritis (2005) (6)
Increased type I collagen degradation correlates with disease activity in reactive arthritis. (2003) (6)
Metabolism of the aminoterminal propeptide of type III procollagen in cultures of human proximal tubular cells. (1992) (6)
Ureido group-specific antibodies are induced in rabbits immunized with citrulline- or homocitrulline-containing antigens (2016) (6)
Type I collagen degradation does not diminish with RA disease duration (2001) (5)
Topical momethasone furoate and betamethasone-17-valerate decrease similarly collagen synthesis in human skin in vivo (1994) (5)
Serum markers of collagen synthesis and degradation in acute respiratory failure patients (2013) (5)
Noninvasive Methods for Detection of Organ (2017) (5)
Effects of long-term inhaled corticosteroids on skin collagen synthesis and thickness in asthmatic patients (1998) (5)
Glomerular basement membrane collagen and activities of the intracellular enzymes of collagen biosynthesis in congenital nephrotic syndrome of the Finnish type. (1978) (5)
INFLUENCE OF LOW CALCIUM, HIGH CALCIUM AND ENERGY-RICH DIETS ON BONE MARKERS IN OVARIECTOMIZED BEAGLE DOGS (1999) (5)
Anthropometrics and biochemical markers in men. (2005) (5)
Modulating influence of barley on the altered metabolism of glucose and of basement membranes in the diabetic rat. (1994) (5)
Connective tissue metabolism and alcohol intake in alcoholic liver disease. (1991) (4)
Measurement of carboxy-terminal propeptide (PICP) and carboxy-terminal, pyridinoline-cross-linked telopeptide (1-CTP) in disorders of bone turnover (1992) (4)
Serial determinations of aminoterminal propeptide of type III procollagen (PIIINP) and prognosis in ovarian cancer; comparison to CA125. (2000) (4)
Correction: Human Bone Marrow Mesenchymal Stem Cells Induce Collagen Production and Tongue Cancer Invasion (2013) (4)
Type-I and type-iii procollagen metabolites and ca 125 in epithelial ovarian-cancer. (1994) (4)
Serum type 1 collagen carboxvterminal crosslinked telopeptide (S-1CTP) in Paget's disease of bone and the effect of treatment with bisphosphonates (1992) (4)
Transdermal estrogen therapy improves lipid profile and osteoporosis in postmenopausal liver transplant patients. (2001) (4)
Role of adhesion molecules in the development of pustular lesions in patients with pustulosis palmaris et plantaris. (1996) (4)
Vasoactive peptides and procollagen propeptides in patients with hypertension in relation to cardiac hypertrophy and diastolic heart failure: design of the study and patient characteristics (2001) (4)
Biomarkers of Disease: Biomarkers of bone formation (2002) (4)
Serum type III procollagen as a marker in liver transplantation. (1990) (4)
Increased type I collagen degradation is associated with a need for total joint replacement surgery in rheumatoid arthritis. (1996) (4)
Carboxyterminal propeptide of type I procollagen in ELF: elevation in asbestosis, but not in pleural plaque disease. (1999) (4)
BASEMENT MEMBRANES ARE CERTAINLY NOT THIXOTROPIC GELS (1981) (4)
Collagen synthesis markers and matrix metalloproteinases 2 (MMP-2) and 9 (MMP-9) in the suction blister fluid and serum of juvenile diabetic patients (1995) (3)
Citrullinated collagens in the pathogenesis of rheumatoid arthritis (2007) (3)
Serum-based test of the pathologic breakdown of type I collagen fibers. (2009) (3)
Increased postoperative concentrations of tenascin-C in wound fluid. (2004) (3)
Serum aminoterminal propeptide of type III procollagen (S-PIIINP) and hepatobiliary dysfunction in patients with ulcerative colitis. (1997) (3)
A simple method for predicting bone fractures in PBC patients after liver transplantation (1994) (3)
Elevated preoperative serum levels of collagen I carboxyterminal telopeptide predict better outcome in early-stage luminal-B-like (HER2-negative) and triple-negative subtypes of breast cancer (2019) (3)
Increased degradation of type I collagen in acne fulminans. (1996) (3)
Rifampicin induces the bone form of alkaline phosphatase in humans (2021) (3)
Effects of glucose on collagen mRNA levels and collagen secretion in EAhy 926 endothelial cell line. (2001) (2)
Basement membrane proteins in human amniotic fluid (1984) (2)
Serum laminin and N-terminal type III procollagen in chronic alcoholic liver disease (1991) (2)
Responses of type I and type III collagen synthesis after replacement of the hip joint. (1995) (2)
A novel type of developmental dentin defect. (1996) (2)
Effect of insulin on serum amino-terminal propeptide of type III procollagen in non-insulin-dependent diabetes mellitus. (1992) (2)
Familial high serum PICP: high even in skin interstitial fluid, suppressible by topical corticosteroid treatment. (2001) (2)
Clinical chemical methods for assessing connective tissue metabolism. (1990) (2)
Physiology of bone resorption during hypocalcemia in dairy cows (1997) (2)
Serum procollagen: A non-invasive index of bone formation in patients on haemodialysis? (1992) (1)
Systemic glucocorticoid decreases the synthesis of type I and type III collagen in human skin in vivo while isotretinoin treatment has little effect (1994) (1)
Effect of gynecological operations on the serum concentration of the aminoterminal propeptide of type III procollagen (1993) (1)
Measurement of epithelial and stromal changes in vulvar carcinoma - a clinical, biochemical and immunohistochemical study. (1995) (1)
A new sensitive bone resorption marker in serum — A cross-linked peptide liqerated during type I collagen degradation, preliminary results in multiple myeloma (1992) (1)
Different amounts of protein-bound citrulline and homocitrulline in foot joint tissues of a patient with anti-citrullinated protein antibody positive erosive rheumatoid arthritis (2013) (1)
Corrigendum to “High dietary intake of retinol leads to bone marrow hypoxia and diaphyseal endosteal mineralization in rats” [Bone 48 (2011) 496–506] (2012) (1)
Circadian variation in new biochemical bone markers in normals (1992) (1)
Automated immunoassays for the autoantibodies to carbamylated or citrullinated telopeptides of type I and II collagens (2015) (1)
Spatial and temporal distribution of laminins in permanent focal ischemic brain damage of the adult rat. (2008) (1)
A controlled study with clodronate in patients with prostate cancer with emphasis to monitore bone metastases using type I collagen metabolites (1992) (1)
Type 1 and 3 collagen production by bone marrow mesenchymal stromal cells is suppressed in vitro after exposure to sepsis patient serum (2015) (1)
Excess dietary vitamin A reduces osteoclast activity in rats (2008) (1)
Effects of systemic isotretinoin on serum markers of collagen synthesis and degradation. (1993) (1)
Collagen turnover and intrauterine growth in small preterm infants (1999) (0)
infarctionserum collagen markers after acute myocardial Atrial natriuretic peptide, B-type natriuretic peptide, (2015) (0)
Wnt11 deficiency and osteoblast differentiation (2015) (0)
Antibody to amino-terminal propeptide of type i procollagen and assay using the same (1996) (0)
Interactions between Myeloma Cells and Osteoclasts Are Controlled by Unique Histological Structures Involving Vascular Compartments. (2005) (0)
Subject Index Vol. 10, 1997 (1997) (0)
rheumatoid arthritis . correlates with disease severity in Increased type I collagen degradation (2004) (0)
Patterns of collagen expression in ovarian tumors (1994) (0)
A Sub-study of the ASCOT Trial Vasoactive peptides and procollagen propeptides in patients with hypertension in relation to cardiac hypertrophy and diastolic heart failure: design of the study and patient characteristics (2001) (0)
Brief Communication Early degradation and serum appearance of type I collagen fragments after myocardial infarction (2004) (0)
Description of A/C gene mutation related dilated cardiomyopathy with gadolinium- enhanced magnetic resonance imaging (2011) (0)
Antikropp Foer I propeptides of procollagen Type iii of the samt bestaemningsmetod color of the anvaends. (1988) (0)
Impact of chemotherapy on collagen metabolism: a study of serum PIIINP (aminoterminal propeptide of type III procollagen) in advanced sarcomas (2005) (0)
Effects of glucose on collagen mRNA levels and collagen secretion in EAhy 926 endothelial cell line. (2001) (0)
[Very high serum concentrations of the carboxyterminal propeptide of type I procollagen (PICP)--a new familial characteristic]. (1995) (0)
A method for detecting the degradation of type I collagen (1992) (0)
138 Myocardial collagen turnover in pressure-overloaded human hearts during the heart failure progression (2005) (0)
Observed Ranges for the Healthy Paediatrics in the Serum IDS-ISYS CrossLaps® (SCTX-I) (2012) (0)
Familially high serum concentrations of the C-terminal propeptide of type I procollagen (1994) (0)
Effect of Trypsin Digestion on the Antigenicity of Purified PIIINP (1999) (0)
Small airway fibrosis in COPD: expression of procollagens I and III (2009) (0)
Osteogenic Differentiation of Human Mesenchymal Stem cells in a 3D Woven Scaffold (2018) (0)
Abstract 55: Further characterization of the human myoma tissue organotypic invasion assay (2012) (0)
39. Intervertebral disc injury may be detected using monoclonal antibodies against procollagen III structures in vivo (1999) (0)
Acid on Serum Biomarkers among Patients with Chronic Low Back Pain and Modic Changes in Magnetic Resonance Imaging. (2019) (0)
Gender-specific modulation of bone remodelling by 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure and ablation of aryl hydrocarbon receptor alters material properties of bone matrix (2011) (0)
An antibody to the propeptide of procollagen type III and test method using thereof (1988) (0)
THE USE OF SERUM AMINOTERMINAL PROPETIDE OF TYPE III PROCOLLAGEN (PSHINP) CONCENTRATION IN PREDICTING THE RESPONSE TO GROWTH HORMONE (GH) THERAPY IN SHORT CHILDREN (1988) (0)
[Clinical benefits of new laboratory tests for collagen metabolism]. (1986) (0)
563 Interleukin‐6 and tumor necrosis factor alpha in relation to myocardial infarct size and collagen formation (2003) (0)
Propeptides and carboxyl-terminal telopeptide of type I collagen in preoperative breast cancer (1998) (0)
Serum type III procollagen in liver transplantation (1989) (0)
Annual serum PICP and ICTP and antler growth in female reindeer (Rangifer tarandus tarandus). (1999) (0)
Effect of elevated serum carboxyterminal telopeptide (ICTP) on survival in breast cancer patients with and without bone metastases (2001) (0)
Ehlers-Danlos syndrome IV . osteodysplastica , De Barsy syndrome , and collagen defect resembling geroderma New lethal disease involving type I and III (0)
A collage Marker in PBC transplant patients (1990) (0)
Serum and liver collagen antigens in HBV disease (1990) (0)
Retraction: Spatial and temporal distribution of laminins in permanent focal ischemic brain damage of the adult rat (2010) (0)
with rheumatoid arthritis . assessment of disease process in patients metabolism in serum and synovial fluid for Application of markers of collagen (0)
Markers of Collagen Turnover and Intrauterine Growth in Small Preterm Infants (1999) (0)
Capsule of abstract: Metformin treatment in premenopausal women with polycystic ovary (2019) (0)
Antibody to propeptide of procollagen, and assay method using it (1987) (0)
P49. Effects of menopause and anti-osteoporosis therapy on circulating collagen propeptides (1996) (0)
FamilialHighSerumConcentrations of the Carboxyl-Terminal Propeptideof Type I Procollagen (1994) (0)
ORGANIC BONE MATRIX IS DEGRADED BY OSTEOBLAST AND BREAST CANCER CELLS LEADING TO RELEASE OF TYPE I COLLAGEN FRAGMENTS IN VITRO (2004) (0)
TCDD-induced modulation of cortical and trabecular bone tissue is dependent on the aryl hydrocarbon receptor (2012) (0)
Platelet Interaction With Basement Membrane Proteins (1981) (0)
Compined effect of physical exercise and estrogens on bone metabolism and mineral density. Two years follow-up (1992) (0)
A method for detecting formed in rheumatoid arthritis autoantibodies (2006) (0)
Bone turnover in polycystic ovary syndrome (PCOS) (2015) (0)
Type III and type I collagen metabolites as predictors of prognosis in ovarian cancer (2000) (0)
PROCOLLAOENS IN OVARIAN TUMORS Table 2 Spearman rank correlations between concentrations of PICP in biological fluids of patients with ovarian tumors (2006) (0)
BONE RESORPTION ASSAY BASED ON A PEPTDE LIBERATED DURING COLLAGEN DEGRADATION (2017) (0)
Contents, Vol. 42, 1985 (1985) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Juha P. Risteli?

Juha P. Risteli is affiliated with the following schools: